Porcine Deltacoronavirus (PDCoV): From Emerging Swine Enteric Coronavirus to a Potential Coronavirus to Infect Humans.
- 1Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Fudan University, Shanghai 200438, China.
Abstract
The global dissemination of coronaviruses continues to pose formidable threats to public health and socioeconomic development, making these viruses a major research priority. Porcine deltacoronavirus (PDCoV), an emerging porcine enteric virus identified over the past two decades, has resulted in substantial economic losses to the swine industry owing to its high mortality and persistent circulation across the globe. Beyond swine, PDCoV possesses a broad host spectrum and is capable of infecting avian species, mice, calves, and other animals. Most alarmingly, its zoonotic potential was highlighted in 2021 through the discovery of PDCoV genomic RNA in pediatric samples from Haiti, highlighting its potential to become the eighth coronavirus species known to infect humans. Despite these dual veterinary and public health threats, licensed vaccines and specific human therapeutics remain unavailable. These facts highlight an urgent demand for comprehensive and in-depth studies on PDCoV to mitigate its potential risks and forestall future outbreaks. This comprehensive review summarizes the latest research advances in PDCoV in four aspects: biological characteristics, epidemiology, pathogenic mechanisms, and antibody development. It is expected that this review can provide a robust theoretical basis for understanding PDCoV infection dynamics and accelerating the development of next-generation, broad-spectrum antiviral strategies to mitigate future interspecies spillover events.
Related
- Low-pH-induced conformational changes in the spike protein promote porcine deltacoronavirus infection by enhancing viral binding efficiency to the porcine aminopeptidase receptor
- DEAD-box RNA helicase 21 interacts with the nucleocapsid protein and inhibits porcine deltacoronavirus infection through upregulation of interferon responses
- Low-Dose Glyphosate Exposure Alters the Enteric Tachykinin System in the Porcine Small Intestine.
- Porcine Reproductive and Respiratory Syndrome Virus: Adaptive Immunity, Immune Evasion and Emerging Strategies for Disease Control.
- Discovery of two potential new species and two novel bat-coronavirus subgenera (Phyllacovirus and Phyllobecovirus) in the Neotropics
BibTeX
@article{chen2026porcine,
title = {{Porcine Deltacoronavirus (PDCoV): From Emerging Swine Enteric Coronavirus to a Potential Coronavirus to Infect Humans.}},
author = {Xiaorong Chen and Zhishui Zhang and Hanyu Cheng and Siyuan Qi and Pengfei Wang},
journal = {Viruses},
year = {2026},
month = sep,
doi = {10.3390/v18101055},
url = {https://europepmc.org/article/MED/42943975},
note = {CC BY},
}
RIS
TY - JOUR
TI - Porcine Deltacoronavirus (PDCoV): From Emerging Swine Enteric Coronavirus to a Potential Coronavirus to Infect Humans.
AU - Xiaorong Chen
AU - Zhishui Zhang
AU - Hanyu Cheng
AU - Siyuan Qi
AU - Pengfei Wang
PY - 2026
DA - 2026/09/23
JO - Viruses
DO - 10.3390/v18101055
UR - https://europepmc.org/article/MED/42943975
AB - The global dissemination of coronaviruses continues to pose formidable threats to public health and socioeconomic development, making these viruses a major research priority. Porcine deltacoronavirus (PDCoV), an emerging porcine enteric virus identified over the past two decades, has resulted in substantial economic losses to the swine industry owing to its high mortality and persistent circulation across the globe. Beyond swine, PDCoV possesses a broad host spectrum and is capable of infecting avian species, mice, calves, and other animals. Most alarmingly, its zoonotic potential was highlighted in 2021 through the discovery of PDCoV genomic RNA in pediatric samples from Haiti, highlighting its potential to become the eighth coronavirus species known to infect humans. Despite these dual veterinary and public health threats, licensed vaccines and specific human therapeutics remain unavailable. These facts highlight an urgent demand for comprehensive and in-depth studies on PDCoV to mitigate its potential risks and forestall future outbreaks. This comprehensive review summarizes the latest research advances in PDCoV in four aspects: biological characteristics, epidemiology, pathogenic mechanisms, and antibody development. It is expected that this review can provide a robust theoretical basis for understanding PDCoV infection dynamics and accelerating the development of next-generation, broad-spectrum antiviral strategies to mitigate future interspecies spillover events.
SN - 1999-4915
ER -